The IDEaL Program supports research to expand our understanding of the establishment, development, and maintenance of immunity across childhood – from birth to 17 years of age. The program aims to provide foundational knowledge on the generation of durable immune responses, development of immune-mediated diseases, and strategies for improving vaccine efficacy in children.
Main Areas of Focus
- Evaluation of age-dependent maturation of immune components in different populations and tissues (e.g., skin, gut, respiratory mucosa)
- Longitudinal assessments following early life exposures (e.g., breastfeeding, environmental agents, infections, allergens)
- Applications of innovative assays and technologies to evaluate immune cell populations and interactions in systems reflecting their physiological environments
Awarded Institutions
- Columbia University Health Sciences
- Ohio State University
- University of California, San Francisco
- University of Massachusetts Medical School, Worcester
- University of Oxford
- St. Jude Children’s Research Hospital
- Boston Children’s Hospital
- Johns Hopkins University
Content last reviewed on